How can scientists effectively communicate the risks of antibiotic resistance to the public and policymakers?

Some P. aeruginosa are becoming more resistant to even antibiotics of last resort, and are described as multidrug-resistant. Mar 31, 2015 ... We establish the P. aeruginosa essential genome with statistical precision in laboratory media and CF sputum. May 23, 2023 ... Carbapenem Resistant Pseudomonas aeruginosa (CRPA) · P. aeruginosa causes an estimated 51,000 health care-associated infections in the U.S. ... The typing database contains nomenclature - allele definitions that provide an identifier for every unique allele sequence, and MLST profiles that index each ... Pseudomonas aeruginosa is the most common strain that causes infections in humans. Around 13% of P. aeruginosa infections are multidrug-resistant (MDR-PA). Mild ... Aug 9, 2017 ... Pseudomonas aeruginosa (P. aeruginosa) is a common Gram-negative, rod-shaped bacterium. It lives primarily in water, soil and vegetation. Some types of Pseudomonas have developed resistance to carbapenems, and these bacteria are called carbapenem-resistant Pseudomonas aeruginosa (CRPA). 2 Ratjen F, Munck A, Kho P, Angyalosi G. Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial. Thorax. 2010 ... Nov 29, 2023 ... Agent Characteristics Risk Group: RG-2 associated with human disease, rarely serious; preventive or therapeutic interventions often available. How is a pseudomonas infection treated? Antibiotics are the main treatment for a pseudomonas infection. It can be hard to find the right antibiotic because the ...